Your browser doesn't support javascript.
loading
Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19.
Miyata, Yoshito; Inoue, Hideki; Hirai, Kuniaki; Ishikawa, Fumihiro; Ohta, Shin; Sato, Haruna; Mochizuki, Kaoru; Ebato, Takaya; Mikuni, Hatsuko; Kimura, Tomoyuki; Fukuda, Yosuke; Kishino, Yasunari; Homma, Tetsuya; Oyamada, Hideto; Kusumoto, Sojiro; Yamamoto, Mayumi; Suzuki, Shintaro; Udaka, Yuko; Tanaka, Akihiko; Ishino, Keiko; Kiuchi, Yuji; Sagara, Hironori.
Afiliação
  • Miyata Y; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan. Electronic address: ym820127@med.showa-u.ac.jp.
  • Inoue H; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Hirai K; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Ishikawa F; Center for Biotechnology, Showa University, Tokyo, Japan.
  • Ohta S; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Sato H; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Mochizuki K; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Ebato T; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Mikuni H; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Kimura T; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Fukuda Y; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Kishino Y; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Homma T; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Oyamada H; Showa University Pharmacological Research Center, Tokyo, Japan.
  • Kusumoto S; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Yamamoto M; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Suzuki S; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Udaka Y; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.
  • Tanaka A; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
  • Ishino K; Division of Infection Control Sciences, Department of Clinical Pharmacy, Showa University School of Pharmacy, Tokyo, Japan.
  • Kiuchi Y; Department of Pharmacology, Showa University School of Medicine, Tokyo, Japan.
  • Sagara H; Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.
Am J Med Sci ; 364(6): 706-713, 2022 12.
Article em En | MEDLINE | ID: mdl-35809647
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cistatina C / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cistatina C / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article